Tag Archives: The Stem Cell Blog

Bacterial Physiology Phage injection establishes CRISPR immunity – Nature.com

Continue reading

2017-04-10 NEWS

Bacterial Physiology Phage injection establishes CRISPR immunity
Nature.com
The CRISPR–Cas system protects bacteria from invaders by acquiring short DNA sequences from infecting viruses. These sequences (spacers) protect against subsequent infection by mediating the cleavage of invading DNA by Cas nuclease. The details of …

Continue reading

2017-04-10 NEWS

Bacterial Physiology Phage injection establishes CRISPR immunity
Nature.com
The CRISPR–Cas system protects bacteria from invaders by acquiring short DNA sequences from infecting viruses. These sequences (spacers) protect against subsequent infection by mediating the cleavage of invading DNA by Cas nuclease. The details of …

Continue reading

2017-04-09 NEWS

Seattle Times

Pioneering work on stemcell therapies at UW deserves state support
Seattle Times
With stemcell biology, we are ready to rebuild solid tissues like the heart and potentially cure our nation’s greatest cause of death and health-care expense. Clinical success will make Washington a destination for heart repair and other regenerative

Continue reading

2017-04-09 NEWS

Stem cells may provide lasting treatment for HF
Healio
The researchers made patches out of stem cells from thigh muscles of the participants. The patches were then surgically glued on to the surface of the participants’ hearts. For patients with ischemic cardiomyopathy, improvements were seen from baseline

Continue reading

2017-04-09 NEWS

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma
Healio
NEW YORK — Mario Sznol, MD, professor of medicine at Yale Cancer Center, discusses whether single-agent or combination immunotherapy should be used to treat patients with melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.

Continue reading

2017-04-09 NEWS

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma
Healio
NEW YORK — Mario Sznol, MD, professor of medicine at Yale Cancer Center, discusses whether single-agent or combination immunotherapy should be used to treat patients with melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.